Radical trifluoromethylation of Ti ate enolate: possible intervention of transformation of Ti(IV) to Ti(III) for radical termination
作者:Yoshimitsu Itoh、Koichi Mikami
DOI:10.1016/j.jfluchem.2006.03.011
日期:2006.5
The radical trifluoromethylation of ketone Ti ate enolates gave α-CF3 ketones in good yields. The use of excess amount of LDA and Ti(OiPr)4 in the preparation of Ti ate enolates is the key to the efficient radical trifluoromethylation. Theoretical studies on the spin density of the Ti(IV) ate ketyl radical intermediate suggest the involvement of transformation from Ti(IV) ate ketyl radical intermediates
酮的Ti的自由基三氟甲基化烯醇化物吃了α-CF 3吨酮以良好的收率。在钛酸酯烯酸酯的制备中使用过量的LDA和Ti(O i Pr)4是有效的自由基三氟甲基化的关键。Ti(IV)酯酮基自由基中间体的自旋密度的理论研究表明,在自由基终止步骤中涉及从Ti(IV)酯酮基自由基中间体向Ti(III)物种的转化。
Facile Radical Trifluoromethylation of Lithium Enolates
作者:Yoshimitsu Itoh、Koichi Mikami
DOI:10.1021/ol0517574
日期:2005.10.1
[GRAPHICS]Highly basic lithium enolates are shown to be applicable to radical trifluoromethylation. The reaction is extremely fast, and the minimum reaction time is similar to 1 s.
Radical trifluoromethylation of ketone Li enolates
作者:Yoshimitsu Itoh、Koichi Mikami
DOI:10.1016/j.tet.2006.03.115
日期:2006.7
It has generally been believed that highly basic Li enolates cannot be applied as substrates for radical trifluoromethylation due to defluorination of the alpha-CF3 product. However, Li enolates can be in fact employed for radical trifluoromethylation. Moreover, the reaction is extremely fast and the minimum reaction time is only similar to 1 s. (c) 2006 Elsevier Ltd. All rights reserved.
FLUOROPYRROLIDINES AS DIPEPTIDYL PEPTIDASE INHIBITORS
申请人:SMITHKLINE BEECHAM CORPORATION
公开号:EP1399433A2
公开(公告)日:2004-03-24
[EN] FLUOROPYRROLIDINES AS DIPEPTIDYL PEPTIDASE INHIBITORS<br/>[FR] FLUOROPYRROLIDINES INHIBITRICES DE LA DIPEPTIDYL PEPTIDASE
申请人:SMITHKLINE BEECHAM CORP
公开号:WO2003002553A2
公开(公告)日:2003-01-09
The present invention relates to novel compounds of following formulae (I)-(VI) their use for inhibiting post prolin/analine-cleaving proteases, such as serine proteases, such as dipeptidyl peptidases, such as dipeptidyl peptidase IV (DPP-IV), and to methods for their production and their therapeutic utility.